
    
      One hundred and five (105) healthy male and female subjects will be randomised in a 4:1 ratio
      to receive a single ocular instillation of Chloroprocaine 3% ophthalmic gel or matching
      placebo (vehicle) (84 subjects will receive chloroprocaine and 21 subjects will receive
      placebo). The assigned investigational product (3 drops) will be instilled in the right eye
      of each subject. Administrations will be performed at the clinical centre by the Investigator
      or his deputy on study day 1. For each administration, the 3 drops will be instilled at a 1
      min Â± 15 sec interval.
    
  